Fortinskaia E S, Torkhovskaia T I, Nalivaĭko E S, Kliuchnikova Zh I, Khalilov E M
Vopr Med Khim. 1989 Mar-Apr;35(2):109-12.
Activity of lecithine-cholesterol acyltransferase (LCAT) was studied in blood of 26 patients with atherosclerosis of various localization after course of treatment involving three-fold hemosorption. The initial activity of the enzyme, decreased distinctly as compared with normal state, was dissimilarly altered during hemosorption. The system LCAT-HDLP was stabilized after the third hemosorption. These results relevant to programming hemosorption therapy of patients with atherosclerosis.